Beta 3 Adrenoreceptor Agonist for the Management of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia: A Systematic Review
Int Neurourol J. 2021 Sep;25(3):182-191. doi: 10.5213/inj.2142068.034. Epub 2021 Sep 30.ABSTRACTBeta-3 adrenoceptor (B3AR) agonist which mediate detrusor relaxation has been tried as a new treatment modality for men with benign prostatic hyperplasia (BPH). However, it remains unclear whether the B3AR agonist has more clinical benefits and fewer adverse effects in men with BPH than in women. We performed a comprehensive search using multiple databases, trials registries, other sources of grey literature, and conference proceedings regardless of language or publication status and included randomized controlled trials. Two re...
Source: International Neurourology Journal - October 6, 2021 Category: Urology & Nephrology Authors: Tae Wook Kang Su Jin Kim Myung Ha Kim Jae Hung Jung Source Type: research